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ABSTRACT  We  have  purified  a glycoprotein  from  chicken  sciatic  nerves,  sciatin,  which  has 
pronounced  trophic  effects  on  avian  skeletal  muscle  cells  in  culture.  Recent  studies  have 
shown that sciatin  is identical  to the iron-transport protein,  transferrin,  in terms of its physi- 
cochemical structure, immunological  reactivity, and biological activity. To determine whether 
transferrin is synthesized and released by neuronal tissue, we incubated cultures of dissociated 
chicken spinal  neurons in a medium free of L-leucine  containing either L-3H-amino  acids or L- 
[14C]leucine  and immunoprecipitated  transferrin with highly specific antibodies. The radiola- 
beled  protein  precipitated  by rabbit  heteroclonal,  goat heteroclonal,  or mouse  monoclonal 
antitransferrin antibodies  increased  in specific activity  in a linear manner for at least 30 min. 
Synthesis of this protein was abolished by the presence of puromycin (20 pg/ml) or cyclohex- 
imide  (10 -5 M). The disappearance  of the  radiolabeled  protein  from  cells  was linear with a 
half-life (t,/2) of 8-10 h. When immunoprecipitates were separated  by SDS gel electrophoresis, 
a prominent  band  corresponding  to  transferrin  (Mr 84,000) was visualized  by  staining  with 
Coomassie  Blue. However, when such gels were fluorographed, no radioactivity was apparent 
in the transferrin region of the gel although a prominent radioactive band was visualized at an 
Mr of 56,000. The protein of Mr 56,000 was not simply a degradation  product  of transferrin 
because this particular protein band was not generated by incubating radiolabeled transferrin 
with unlabeled neuronal homogenates. The protein of Mr 56,000 was purified from embryonic 
chicken  brain and spinal  cord  by immunoabsorption  chromatography on mouse monoclonal 
antitransferrin  IgG  conjugated  to  Sepharose  4B  followed  by  affinity  chromatography  on 
immobilized  transferrin.  The purified  protein  bound  radioiodinated  transferrin  and was pre- 
cipitated  by  rabbit  anti-chicken  transferrin-receptor  antibodies.  Furthermore,  this  receptor 
protein was found  to be localized on the plasma  membrane of dorsal  root ganglion  neurons 
by  immunocytochemistry  using  the  peroxidase-antiperoxidase  technique,  and  by  blocking 
experiments,  which  showed  that  antitransferrin  receptor  IgG  could  inhibit  the  binding  of 
fluorescein-conjugated  transferrin  at 4°C to cultured  neurons  in  vitro.  From  these  data,  we 
conclude  that transferrin  is not synthesized  by cultures  of chicken  spinal  cord  neurons,  but 
that  the  receptor  for  transferrin  is  synthesized  by  these  cultures  and  is  precipitated  by 
antitransferrin antibodies as an antigen-receptor complex. 
This laboratory has purified an acidic, myotrophic glycopro- 
tein,  sciatin,  from the  sciatic nerves  of adult  chickens (1). 
Sciatin has been shown to promote the morphological matu- 
ration and maintenance of chicken muscle cells in culture (2), 
to increase protein synthesis in postmitotic myotubes (3), to 
promote and maintain the aggregation ofacetylcholine recep- 
tors into clusters (4),  and to be an essential component for 
the initial differentiation of cultured chicken myogenic cells 
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showed  that  sciatin  is  localized  in  the  perikarya of spinal 
neurons and the axoplasm of sciatic nerves in the chicken (6). 
Recent studies have shown that sciatin is identical to the iron- 
transport protein, transfelTin, in terms of its physicochemical 
structure, immunological reactivity, and biological activity (7, 
8). 
In view of the numerous myotrophic effects of transferrin 
upon skeletal muscle, and the fact that the protein is so well 
localized in the cell bodies and processes of spinal neurons, 
we anticipated that this protein might represent a myotrophic 
substance  synthesized  and  secreted  by  neurons.  In  fact,  a 
recent report by Stamatos et al. (9) demonstrated that trans- 
fen'in  is  indeed  synthesized  and  released  by  embryonic 
chicken spinal cord neurons in vitro (see also reference 10). 
Thus,  we  decided  to  investigate  further  the  synthesis  and 
release oftransferrin by cultured embryonic chicken neuronal 
tissue. In the present communication, we report the following: 
(a) a protein precipitable by antitransferrin antibodies is syn- 
thesized in  neuronal cultures exposed to radioactive amino 
acids; (b) this labeled protein migrates at an Mr of 56,000 on 
SDS gels and is not transferrin or a  degradation product of 
transferrin; (c) this 56,000-Mr protein appears to represent a 
receptor or binding protein for transferrin that is immunopre- 
cipitated by antitransferrin antibodies as part of a transferrin/ 
transferrin receptor complex; and (d) this 56,000-Mr protein 
is  present  on  the  surface  of neurons  as  evidenced  by  its 
immunocytochemical localization  with  rabbit  anti-chicken 
transferrin-receptor antibodies, and by blocking studies with 
antireceptor lgG that showed that pretreatment of cells with 
antireceptor IgG could inhibit the surface binding of fluores- 
cein-conjugated transferrin to living neurons. 
MATERIALS  AND  METHODS 
Cell Culture:  Spinal cord tissue from 10-d-old chicken embryos (Spa- 
fas, Inc., Norwich, CT) was dissociated in 0.2% trypsin and plated on collagen- 
coated Linbro plastic dishes (35 x  15 mm; FB-6-TC; Flow Laboratories, Inc., 
McLean, VA) at a density of 3 ×  106 cells/dish. Dorsal root ganglia tissue from 
12-d-old  chicken embryos was dissociated and plated in an identical fashion at 
a density of  2.0-5.0 × I 05 cells/dish (6). The standard culture medium consisted 
of 80%  Dulbecco's  modified  Eagle's medium  (DME~; high  glucose; Gibeo 
Laboratories, Grand Island, NY),  15% horse serum (North American Biologl- 
cals, Inc., Miami, FL; heat-inactivated and Millipore-filtered), and 5% chicken 
embryo extract (l 1). Cytosine arabinoside (10  -5 M) was present in the medium 
for the  first  3 d  of culture  to kill rapidly  proliferating  non-neuronal  cells. 
Cultures were maintained  at 36.5"C in a humidified  atmosphere  of 95% air/ 
5% CO2. The culture medium was changed every third day and no antibiotics 
were used. 
Preparation of Monoclonal Antibodies:  Monoclonal antibodies 
against chicken transferrin were produced using a modification of  the procedure 
of Kenneth et at. (12). Balb/C  female mice (8-wk-old; Jackson  Laboratories, 
Bar Harbor, ME) were immunized bysubcutaneous injection with 50-100  ,g 
of purified  transferrin  on days  0,  7,  and  14.  The first injection  was in the 
presence of complete Freund's adjuvant  (Difco Laboratories, Detroit, MI) and 
later injections were in the presence of incomplete Freund's adjuvant.  On day 
21, transferrin was injected intravenously and the spleens were removed on day 
24.  Spleen  cells were harvested  by grinding  the organs  between the frosted 
surfaces of microscopic  slides, and these  cells (108  ) were fused with  mouse 
myeloma cells (SP 2/0-Ag  14,  108 cells) in the presence of 50% polyethylene 
glycol 1000 (J. T. Baker Chemical Co., Brick Town, NJ). Cells were suspended 
in DME containing  20% fetal bovine serum (Gibco Laboratories), distributed 
into Costar 96-well plates (Cambridge, MA) and incubated  overnight at 37"C 
t Abbreviations used in this paper. APB,  antiprotease buffer; DME, 
Dulbecco's modified  Eagle's medium; DRG, dorsal  root ganglion; 
FITC,  fluorescein  isothiocyanate;  PAP,  peroxidase-antiperoxidase; 
TCA, trichloroacetic acid; Tf, transferrin; TfR, transferrin receptor. 
in a humidified  atmosphere  of 90%  air/10%  CO:.  The culture  medium was 
replaced on days 1, 3, and 5 with HAT medium (DME containing  20% fetal 
bovine serum,  10% NCTC 135, 100 vM hypoxanthine,  1 t~M aminopterin,  and 
16 ttM thymidine), and on days 7, 9, and 11 with HT medium (DME containing 
20% fetal bovine serum,  10% NCTC 135, 100 ~M hypoxanthine,  and  16 #M 
thymidine).  On days  12-15,  visible clones were noted  and the supernatants 
were tested for antibody  to transferrin  by an enzyme-linked  immunosorbent 
assay established in this laboratory (Cha, C. Y., T. H. Oh, S. H. Shim and G. 
J. Markelonis, unpublished data). Positive clones were grown on 35-mm dishes 
and  established  as ascites tumors in  Balb/C  female  mice  which  had  been 
sensitized with Pristane  (Aldrich Chemical  Co.,  Metuchen,  N  J). The ascites 
fluid from clone 2E 12/47 had a titer of 1:250,000 against chicken transferrin 
and was therefore used in these experiments. 
Immunocytochemical  Procedure:  Spinal  cord  cultures  were 
rinsed  with  PBS and  fixed in either  absolute  methanol  for 30  min or 4% 
paraformaldehyde-0.1%  glutaraldehyde in 100 mM cacodylate buffer, pH 7.2 
for 1 h. Transferrin was visualized immunocylochemically  on methanol-fixed 
cultures by the peroxidase-antiperoxidase  (PAP) procedure of Sternberger (13) 
using rabbit  anti-chicken  transferrin  serum (diluted  1:100 with  PBS) as de- 
scribed previously (6). Preimmune rabbit  serum was used as a control.  The 
transferrin  receptor  was visualized  on  aldehyde-fixed cultures  by the  PAP 
procedure using rabbit anti-chicken transferrin  receptor lgG (14) at a concen- 
tration  of 100 #g/ml in PBS. This antibody  was prepared against transferrin 
receptors purified from embryonic chicken erythrocytes. This IgG fraction was 
shown to agglutinate embryonic  chicken reticulocytes, a process which could 
be inhibited  by preincubation  with the  Fay fragments  of this  IgG, to cause 
complement-mediated  red cell lysis and to inhibit the uptake of [~SFe]transferfin 
by these cells (14). Preimmune rabbit IgG was used as a control. 
Isotopic Labeling of Cultures:  Newly synthesized proteins in 7-d- 
old cultures were routinely labeled in the presence of 10 uCi L-3H-amino acids 
(New England Nuclear, Boston, MA; NET-250; approximate  specific activity, 
7.7 Ci/mmol) in L-leucine-free DME (custom  product;  KC Biologlcals, Inc., 
Lenexa,  KS) or, on some occasions, in  10 uCi L-[~4C]leucine (New England 
Nuclear:  40  Ci/mmol) in  the  same  medium.  To  inhibit  protein  synthesis, 
puromycin (20 #g/ml [ 15]) or cycloheximide ( 10  -5 M [ 16]) was added 4 h or I 
h. respectively, before addition  of isotope. The labeling reaction  was stopped 
by washing cultures thrice with 1.0-ml portions of  an antiprotease buffer (APB) 
consisting of 10  mM sodium  phosphate,  pH 7.2, 5 mM L-leucine, 10 ug/ml 
leupeptin. 0.5 trypsin-inhibitor  U/ml aprotinin,  and 1 mM EGTA. On certain 
occasions, APB was further  supplemented  with 5 mM phenylmethylsulfonyl 
fluoride, but this protease inhibitor  had  no recognizable effect on the results 
obtained  with  routine  APB. The cells were then scraped from the  dish and 
disrupted  in  1.0  ml of APB in a  Polytron  homogenizer  (Brinkmann  Instru- 
ments.  Inc., Westbury,  NY). The supernatant  obtained  after  centrifuging at 
1,000 g for 20 min was utilized in immunoprecipitation  experiments. 
Immunoprecipitation:  The post-l,000  g supernatant obtained above 
was mixed with  an equal  volume  of either  rabbit  heteroclonal  anti-chicken 
transferrin serum (final titer,  1:4 [6]), goat heteroclonal anti-chicken transferrin 
serum (final titer,  1:4) or mouse monoclonal anti-chicken transferrin antibody 
(2E 12/47 ascites fluid; final titer, 1  : 10,000) in PBS. Control experiments showed 
that  these  antibody  dilutions  all  gave quantitative  immunoprecipitation  of 
radiolabeled transferrin.  After incubation  overnight at 4"C, the immune com- 
plexes present  were precipitated  by centrifuging at  1,000 g  for 20  min.  For 
quantitative  experiments,  the pelleted antigen-antibody  complexes were pre- 
cipitated with 1.0 ml of 10% trichloroacetic acid (TCA), collected by centrifug- 
ing at  1,000 g, dissolved in  1.0 N NaOH and counted  in  10 mI of Aquasol 
(New England Nuclear) acidified with an appropriate quantity of 10% TCA to 
clarify the sample. 
Electrophoresis  and  Fluorography:  For electrophoresis  experi- 
ments,  immunoprecipitates  labeled  with  L-[~4C]leucine were dissolved  in  a 
buffer consisting of 10 mM Tris-HCl, pH 8.0, I mM EDTA. 2% SDS, 5% 2- 
mercaptoethanol,  4  M  urea.  and  25%  sucrose  at  100*C for  10  rain.  The 
immunoprecipitates  were separated on 12.6% SDS gel electrophoresis, and the 
gel  proteins  were stained  with  Coomassie  Blue and destained  as previously 
described (17; also see reference 2). The dehydrated gels were rehydrated with 
1% glycerol in  10%  acetic acid for 2 h and  dried  using a  Bio-Rad gel dryer 
(Bio-Rad Laboratories, Richmond,  CA). The dried gels were placed in contact 
with Kodak XAR-5 film in a Kodak X-Omatic cassette (Eastman  Kodak Co., 
Rochester, NY), and the fluorographic film was exposed for 14 d at 4"C. The 
exposed film was developed in Kodak GBX developer by the standard method. 
Transferrin Radiolabeling:  Transferrin (Tf) was purified from either 
chicken serum or chicken sciatic nerves by affinity chromatography on concan- 
avalin A-agarose followed by ion exchange on DEAE cellulose as previously 
described (7), or was obtained  commerically (Sigma Chemical Co., St. Louis, 
MO). The protein was labeled by reductive methylation  as described by Tack 
et al. (18). The protein  (3  nmol) was methylated  in the presence of 1 umol 
MARKELONIS ET At,  Transferrin  Receptors in Neurons  9 HOMOGENIZE EMBRYONIC BRAIN AND SPINAL CORD TISSUE (13-15-DAY OLD) IN 
EQUILIBRATION BUFFER  (EB; 10 mM POTASSIUM PHOSPHATE, pH 7.5,  150 mM 
NaCI, 0.1% TRITON X-100; 1.0 g/ml) 
I  CENTRIFUGE (16,000 x  30 min, 4°C1  g, 
t 
SUPERNATANT 1  PELLET (DISCARD) 
(i)  (NH4)2SO  4 PRECIPITATION 
(0.315 g solid (NH4)2SO  4 
per ml suP1; stir 15 rain at 4°C) 
(ii)  CENTRIFUGE (16,000 x g, 30 min, 
4oc) 
SUPERNATANT  2 
(DISCARD) 
FLOATING PELLET 
l 
(i)  COLLECT 
(ii) DIALYZE x EB (18h,  4°C) 
*ANTITRANSFERRIN  AFFINITY COLUMN (MOUSE  2E12/47 ANTICHICKEN 
TRANSFERRIN CONJUGATED TO CNBr-ACTIVATEO SEPHAROSE  4B) 
WASH  #1: EB (SCREEN  ELUENT BY FLUORES- 
CAMINE ASSAY) 
WASH  #:2:10 rnM POTASSIUM PHOSPHATE, pH 
7.5, 500 mM NaCI (SCREEN  BY 
F LUORESCAMINE ASSAY) 
WASH  #:3: SAME AS WASH #:1 ABOVE 
f 
PROTOCOL #2 
WASH #4:8 M UREA, 0.5% TRITON 
X-100  ~ 
(i)  POOL ELUTED FRACTION 
(WASH #4) 
(ii) DIALYZE x  EB (18-36h,  4°C. 
4 buffer changes) 
*TRANSFERRIN AFFINITY COLUMN 
(TRANSFERRIN, SIGMA, TYPE 2, 
(i)  (CONJUGATED TO CNBr-ACTIVATED 
(iii)(ii)  SEPHAROSE 4B)~ 
WASH #:1 (VIDE SUPRA} 
WASH  #2:10 mM POTASSIUM PHOSPHATE, 
pH7.5,  1MNaCI 
WASH  #3: EB (VIDE SUPRA) 
WASH  #4:8 M UREA, 1.0% TRITON X  100 
(i)  POOL ELUTED FRACTION 
(WASH #4) 
(ii)  DIALYZE x  EB (18-36 h, 
4°C, 4 buffer changes) 
(iii)  STORE IN EB AT 4oc WITH 
0.02%  NaN  3 
FIGURE  1  Purification  protocols  for the transferrin  receptor. 
t 
PROTOCOL #I 
WASH #4:20 mM BORATE/NaOH, pH 10.0, 
500 mM NaCI, 0.5% TRITON X-100 
(SCREEN  BY FLUORESCAMINE  ASSAY) 
WASH  #5:50 mM POTASSIUM PHOSPHATE/ 
PHOSPHORIC ACID, pH 2.0, 150 mM NaCI 
(SCREEN  BY FLUORESCAMINE  ASSAY) 
POOL PEAKS #4 and 5 
DIALYZE x EB (18h, 4°C) 
STORE AT -20°C in EB or in 
EB containing 10% glycerol 
H~*CHO (New England Nuclear, 55 mCi/mmol) and 0.3 #tool NaBI-L for 10 
rain at 0*C in 0.2 M sodium borate buffer, pH 9.0 (final reaction volume, 300 
ul). The ~4C-methylated protein  was then desalted on a column of superfine 
Sephacryl S-200 (Pharmacia  Fine  Chemicals,  Piscataway, NJ) and dialyzed 
extensively against Hanks' balanced salt solution. The ~4C-methylated protein 
had an average specific activity of 8.0 x  l& dpm/mg, migrated as a single band 
on SDS gel electrophoresis and was quantitatively precipitated by goat antitrans- 
ferrin antibodies (95%). Transferrin (75 tzg) was radioiodinated in the presence 
of 1.0 mCi Na~2SI (carder-free; New England Nuclear) to a specific activity of 
4.4 ~Ci/~g using the chloramine-T  method of Hunter and Greenwood  (19). 
Free  NaK251 was  removed  from the  iodinated  protein  by  gel  filtration  on 
superfine Sephacryl S-200 using  10% heat-inactivated  horse serum in PBS as 
the eluent. The labeled protein was stored as aliquots at -20"C. The iodinated 
protein  migrated as a single band on SDS gel electrophoresis and was quanti- 
tatively precipitated by goat antitransferrin  antibodies (80%). 
Purification of Transferrin Receptors from Chicken Neural 
Tissues:  Brain and spinal  cord  tissues were harvested  from  13-15-d-old 
chicken embryos, washed in Hanks', and blotted dry. The tissues were homog- 
enized  in  10 mM potassium  phosphate  buffer, pH 7.5  containing  150 mM 
NaCI and 0.1% Triton X- 100 (1.0 g of  tissue/ml) using a Polytron homogenizer 
(20). Preliminary  studies showed that Triton X-100 or SDS was required for 
complete solubilization of the 56,000-34, protein from embryonic neural tissue. 
The  homogenate  was centrifuged  at  16,000 g  for 30  rain  at  4"C  and  the 
supernatant was collected. The transferrin  receptor (TfR) was purified by the 
protocols shown in Fig. 1, which are based on the procedure originally described 
by Seligman et at. (20). Mouse monoclonal  anti-chicken  transferrin  lgG was 
purified from ascites fluid (2E12/47)  by DEAE Am-Gel  Blue column chro- 
matography (Bio-Rad product  bulletin  no.  1062, Richmond,  CA) and conju- 
gated to cyanogen bromide-activated Sepharose 4B (Pharmacia Fine Chemicals) 
at a ratio of 10 nag of  lgG/g Sepharose by a standard procedure (2 t ). Transferrin 
(Sigma Chemical Co., conalbumin,  type II) was conjugated to cyanogen bro- 
mide-activated Sepharose 4B in an identical manner. Where specified, column 
fractions  were  screened  by  the  fluorescamine  assay  (22) using  a  Farrand 
spectrophotofluorometer  (Fan-and Optical Co.,  Inc., Valhalla, NY).  Column 
peaks were pooled and the protein composition  of each peak was determined 
by SDS gel electrophoresis. Immunoreactivity of  proteins against antitransferrin 
antibodies was tested by a double-immunodiffusion  assay in agar as previously 
described (6). 
Transferrin Receptor (TfR) Binding to  12SI-Transferrin ('2Sl- 
Tf):  Biologically active TfRs were purified using protocol  2 as outlined  in 
Fig.  1. Even though these receptors were purified by affinity chromatography 
on immobilized Tf, we further tested their ability to bind 12SI-Tf  by using a gel 
filtration procedure. Purified TfRs were mixed with t251-Tf  (g I ng; 4.6/~Ci/~g) 
in  equilibration  buffer  and  the  mixture  was stored  overnight  at  4"C. The 
resulting 12SI-Tf/TfR  complexes were separated from free t2~I-Tfon a calibrated 
column (1  x  50 era) of superfine Sephadex G-200 at a flow rate of 2.0 ml/h 
using equilibration buffer as the eluent. Fractions of  0.35 ml were collected and 
counted  in a  "r-counter. Calibration  proteins  were chromatographed  under 
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elution profile. The approximate molecular weight of the Tf/TfR complex was 
ascertained by comparing its relative elution volume with those obtained for 
the calibration proteins. 
Binding of fluorescein Isothiocyanate  Transferrin to Neu- 
ronal Cultures:  Transferrin  (15 nag; Sigma Chemical Co.) was reacted in 
the dark with 100 #g of fluorescein isothiocyanate (FITC; Sigma Chemical Co.) 
for 1 h at room  temperature in  1.0 M NaHCO3, pH 9.5 (23). The FITC- 
conjugated protein was then purified by gel filtration on a 1.0 x 30-cm column 
of superfine Sephacryl S-200 using PBS as the eluent. The protein peak was 
localized by screening column fractions for absorbance at 280 nm in a spectro- 
photometer, and by screening for fluorescence in a spectrophotofluornmeter 
(excitation, 495; emission, 520). The pooled peak was dialyzed overnight in the 
dark at 4"(:? against PBS and had a fluorescence yield of 1.94 fluorescence  U/ 
ug of protein. For binding experiments, dorsal root ganglion (DRG) cultures 
grown on glass coverslips  as described above were incubated in the presence of 
29-86 ug of FITC-Tfat 4"C for 2 h after a 2-h preincubation in 1% preimmune 
serum. For internalization studies, receptors were saturated with 29-86 ug of 
FITC-Tf  for 30 rain at 4"C and then moved to a 37"C incubator for 90 rain. 
TfR blockade was accomplished by pretreating cultures for 2 h with 45-90 ~g 
of rabbit antitransferrin receptor IgG in PBS at 4"C. All experiments were 
accompanied by appropriate controls in which cultures were incubated with 45 
ug of FITC-Tf +  500 ug of uneonjugated Tf to assess nonspecific binding. 
Cultures were mounted live in 10 mM para-phenylenediamine in 90% glycerol 
at pH 8.6 (24). The cultures were examined under a Zeiss fluorescence micro- 
scope (Oberkochen, Federal Republic of Germany); photographs were taken 
by using a x40 objective at an exposure setting of 22 s with llford HP-5 film 
(Ciba-Geigy, Basildon, Essex, England). 
RESULTS 
The  morphological  development  of  the  dissociated  chick 
spinal cord cultures was similar to that described previously 
(25). After 7 d  in vitro, numerous well-differentiated neurons 
lying atop a  non-neuronal  cell monolayer could be observed 
using a  Zeiss Invertoscope under  phase-contrast  optics.  De- 
spite the presence of these non-neuronal cells, neuronal peri- 
karya and their processes were clearly apparent. 
Synthesis and Turnover of Protein  Precipitable 
by Antitransferrin  Antibodies 
Control experiments were carried out to optimize the con- 
centrations of  goat heteroclonal, rabbit heteroclonal, or mouse 
monoclonal anti-chicken transferrin antibodies for immuno- 
precipitation of transferrin.  Precipitation was quantitative at 
antisera dilutions  of 1:4,  1:4,  and  l: 10,000,  respectively. In- 
asmuch as these experiments showed that the specific activity 
of 3H-labeled neuronal proteins increased linearly for at least 
120 min  (Fig. 2),  the absence  of L-leucine from the labeling 
medium  for relatively short  periods did not adversely affect 
either the viability of the cells or their capacity to synthesize 
proteins de novo. 
To  detect  transferrin  synthesized  de  novo,  cultures  were 
labeled  for  varying  time  periods  in  the  presence  of L-3H  - 
amino acids, and the protein was precipitated from the post- 
1,000  g  supernatant  with  either  rabbit  heteroclonal,  goat 
heteroclonal,  or mouse  monoclonal anti-chicken  transferrin 
antibodies.  As the experiment in Fig. 3 indicates, incorpora- 
tion  of label  into immunoreactive protein  was  linear for at 
least 30 min (ks =  0.015  min-l; r  =  1.0) and was diminished 
95%  by preincubating  cultures  for 4  h  with  puromycin  (20 
#g/ml;  Fig.  3)  or  by  94%  by  preincubating  for  I  h  with 
cycloheximide  (10 -5  M;  not  shown).  Other  experiments 
showed  that  ~7%  of the  counts  incorporated  into  protein 
appeared in radiolabeled immunoprecipitates. A  linear incor- 
poration  of labeled  amino  acids  into  immunoprecipitable 
protein  was  observed  regardless  of whether  rabbit  hetero- 
clonal, goat heteroclonal, or mouse monoclonal anti-chicken 
5.0 
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40  80 
Time (rain) 
FIGURE 2  Total protein synthesis in cultures of embryonic chicken 
spinal  neurons.  Cultures  of dissociated  spinal  neurons  (11-d-old) 
were washed thrice with  L-leucine-free  DME and  1.0 ml of this 
medium was added to each culture dish.  10 #Ci L-3H-amino acids 
was then added to each culture.  The labeling reaction was stopped 
at timed intervals by aspirating the medium, washing the cultures 
thrice  with  APB  (see Materials  and  Methods) and  precipitating 
cellular proteins with 1.0 ml of ice-cold 10% TCA. The dishes were 
then reextracted with 10% TCA, washed three times with ethanol- 
ether (3:1) and air-dried. 1 ml of 0.1  N NaOH was then added to 
each dish and noncollagen protein was solubilized overnight (26). 
Counts incorporated into noncollagen protein were determined in 
duplicate by counting portions of the soluble alkaline extract in 10 
ml of Aquasol using a Searle Mark III  liquid scintillation counter 
(Des Plaines, IL) at 50% efficiency. Noncollagen protein was deter- 
mined by the method of Lowry et al. (27). Each point represents 
the  mean  +  SE  of  four  determinations. Least squares analysis 
showed that the data were fitted to a straight line (r = 0.98). 
5o 
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FIGURE 3  Synthesis of protein precipitable by rabbit antitransferrin 
antibodies in cultures of dissociated spinal neurons. In this experi- 
ment, 7-d-old neuronal cultures were incubated in the presence of 
3H-amino  acids as described in  Materials  and Methods and the 
legend  to  Fig. 2.  Some cultures  had  been preincubated in  the 
presence of either puromycin (20 #g/ml) for 4 h or cycloheximide 
(10  -s M) for 1 h. At timed intervals the cells were washed  thrice 
with APB, harvested, and homogenized  in 1.0 ml of APB. A portion 
of each homogenate  was used for determining noncollagen  protein, 
and the supernatant that was obtained by centrifuging the remain- 
der  of  the  homogenate at  1,000  g  for  20  min  was  incubated 
overnight at  4°C with  an  equal volume of rabbit antitransferrin 
antibodies in PBS (final titer, 1:4). The immunoprecipitates formed 
were collected by centrifugation and processed for liquid scintilla- 
tion counting as described  in Materials and Methods. Values rep- 
resent the mean +  SE of triplicate determinations. The data were 
fitted to a straight line by least squares analysis (r -- 1.0). Puromycin 
inhibited  incorporation  into  immunoreactive  protein  by  95% 
whereas  cycloheximide  inhibited  incorporation  by  94%  (not 
shown). 
transferrin antibodies were used for immunoprecipitation. 
To estimate  the turnover  of immunoreactive  protein,  we 
pulse-labeled neuronal cultures for 30 min with  l0 #Ci L-3H  - 
amino acids, the cultures were washed several times with 85% 
DME/15% horse serum, and antitransferrin-precipitable pro- 
tein  was  determined  in  cells and  in  the culture  medium  at 
timed  intervals.  As shown  in  the experiment  in  Fig.  4,  the 
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life (t,/2) of ~8-10 h. About 10-12% of  this precipitable protein 
was released into the culture medium in a linear fashion and 
this release occurred during only the initial 90 min after pulse- 
labeling (not shown). Thereafter, the rate of release decreased 
to  zero.  During  this  latter  stage,  intraceUular  degradation 
appeared  to  account  for  the  continued  linear  turnover  of 
immunoreactive protein. 
The Immunoprecipitated Protein Synthesized by 
Neuronal Cultures Is Not Transferrin 
To test the specificity of the anti-chicken transferrin anti- 
bodies,  we  separated  some  radioactive immunoprecipitates 
obtained after  labeling neuronal cultures for 30 min with [t4C]- 
leucine on  12.6%  SDS gels, stained the gels with Coomassie 
Blue, and  fluorographed the dehydrated electropherograms. 
As shown  in  Fig.  5 A, Coomassie Blue  staining revealed a 
prominent protein band, which co-migrated with a transferrin 
standard  (lane  S;  Mr  =  84,000).  However, fluorographs of 
such gels (Fig.  5 B) showed no radioactivity in the transferrin 
region of the gel, but did reveal a single, prominent band with 
a M, of 56,000. To determine whether this 56,000-3,/, protein 
represented a degradative fragment of transferrin, we added 
~4C-labeled transferrin  to  unlabeled  neuronal  homogenates 
and precipitated the protein by the standard immunoprecip- 
itation technique.  As shown in Fig.  5 B, the labeled immu- 
noprecipitated protein migrated at an Mr of 84,000 with no 
apparent degradation into a  56,000-M, fragment. To deter- 
mine which cells were immunoreactive to antitransferrin an- 
tibodies, we fixed and stained cultures by the PAP technique. 
As shown in Fig. 5 C, only neurons and their processes reacted 
appreciably with the antitransferrin antibodies. 
Radiolabeled  Transferrin  Receptors  Co- 
precipitate  with  Unlabeled  Transferrin 
The transferrin obtained by immunoprecipitating the radi- 
olabeled proteins synthesized by neuronal cultures was not 
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FIGURE  4  Turnover of protein precipitable by goat antitransferrin 
antibodies in  neuronal cultures.  7-d-old  neuronal cultures were 
labeled with 3H-amino acids for 30 min as described in Materials 
and Methods. Cultures were then washed thrice with 85% DME- 
15% horse serum, and 3H-protein precipitable by goat antitransfer- 
rin antibodies was determined in cells  and in the incubation me- 
dium at timed intervals. The fractional percentage of counts within 
cells as shown here decayed in a linear fashion  with an estimated 
turnover time (t,/,) of  8.6  h.  Each value  represents  the  mean  of 
duplicate determinations. 
FIGURE  5  Synthesis  of a  protein  of 56,000  tool wt  by  neuronal 
cultures that co-precipitates with transferrin and the immunocyto- 
chemical localization of transferrin in cultured neurons. (A) Immu- 
noprecipitates from neuronal cultures labeled in the presence of L- 
[14C]leucine for 30 min were separated by SDS gel electrophoresis 
and the proteins were visualized with Coomassie Blue. The immu- 
noprecipitate in  lane  I shows  three major bands that correspond 
to:  top--transferrin, middle-heavy chains  of  IgG,  and  bottom-- 
light chains of IgG. Notice that transferrin in lane / co-migrates with 
a transferrin standard  in lane S. (B) An electrophoretic  gel obtained 
as  in  A  above was  dehydrated and  fluorographed for  14  d  as 
described in  Materials and  Methods. The fluorograph of the im- 
munoprecipitate (lane I) had no radioactive band corresponding to 
transferrin  (Mr =  84,000).  However, a prominent band was visual- 
ized  at  an  Mr  =  56,000.  Lane T shows  an  immunoprecipitate 
obtained by mixing an unlabeled neuronal homogenate containing 
[~4C]transferrin (28,000  dpm) with goat antitransferrin IgG.  Notice 
that the 14C-labeled transferrin was precipitated by antibody and 
that  no  faster-migrating, degradative fragments were  generated 
during the immunoprecipitation procedure. (C) A spinal  cord cul- 
ture was fixed and stained by the peroxidase-antiperoxidase  tech- 
nique using  rabbit antitransferrin serum as described in  Materials 
and  Methods.  The  culture  was  photographed using  bright-field 
optics at a magnification of 100. Notice the localization of reaction 
product in  a spinal  neuronal cell body  (large arrowhead) and  its 
processes (small arrowheads). Contaminating non-neuronal cells (*) 
are not stained  by the antiserum. Control cultures incubated with 
preimmune serum showed no reaction product in  neuronal cells 
(not shown), k, x  10  -3 (molecular weights). 
itself radioactively labeled (Fig.  5 B), even though transferrin 
was present  in  abundance  within  cultured  neurons  as  evi- 
denced  by the  peroxidase-antiperoxidase technique  (Fig.  5 
C). Also, the antiprotease mixture (APB) used to homogenize 
cultures appeared to be of a suitable composition to prevent 
the degradation of ~4C-labeled transferrin into either a 56,000- 
Mr fragment or other still smaller fragments (Fig.  5 B). Addi- 
tional  control  experiments  showed  that  these  observations 
were unchanged by using citrate buffer at pH 4.2 to homog- 
enize the cultures in that citrate has been observed to have a 
stabilizing effect on transferrin (28). Also, the results were not 
affected by increasing the concentration of unlabeled L-leu- 
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itors such as phenylmethylsulfonyl fluoride to the homoge- 
nizing mixture or by using various other lots of anti-chicken 
transferrin antibodies. In view of these negative findings,  we 
wondered whether the 56,000-Mr protein represented a recep- 
tor for transferrin (14) which coprecipitated with transferrin 
in the presence of antitransferrin antibodies (29).  Therefore, 
we attempted  to isolate the  putative neuronal transferrin- 
56,000-Mr  protein (receptor) complex on immobilized mon- 
oclonal antitransferrin IgG and to purify the receptor protein 
by differential desorption at alkaline pH in the presence of 
0.5% Triton X-100 (protocol 1, Fig.  1; see reference 20). 
FIGURE  7  Double-immunodiffusion  precipitin reaction of goat an- 
titransferrin  serum with the transferrin receptor and with transferrin. 
Center well, goat antitransferrin  serum diluted 1:3 with PBS; lanes 
1, 3, and 5, transferrin  receptor (peak A of Fig. 5; 100 #g/ml); wells 
2, 4, and 6, transferrin  (peak B of Fig. 5; 100 #g/ml). 
Purification of the Neuronal Transferrin Receptor 
by Selective Desorption from Antitransferrin  tgG 
Fig.  6  shows  a  step-elution profile of neuronal  proteins 
desorbed  from  mouse  monoclonal anti-chicken transferrin 
IgG (2E12/47) conjugated to Sepharose 4B (protocol 1, Fig. 
1). The pooled, stippled fraction eluted by 20 mM borate/ 
NaOH, pH 10.0 containing 0.5 M NaC1 and 0.5% Triton X- 
100 (Fig. 6, peak A) was found to contain a highly purified 
protein of Mr 56,000 as judged by SDS gel electrophoresis 
(Fig.  6,  inset).  After  the  appearance  of peak  A,  proteins 
remaining absorbed to the column shown were stripped from 
the IgG using 50 mM potassium phosphate/phosphoric acid, 
pH  2.0,  containing  150  mM  NaCI (see  reference 20).  The 
pooled, stippled fraction eluted by this buffer (Fig. 6, peak B) 
was found to contain several proteins on SDS gel electropho- 
resis (Fig. 6, inset);  one of these proteins co-migrated with a 
transferrin standard (not shown), while another appeared to 
FIGURE 8  SDS gel electrophoresis  of purified transferrin receptors. 
Transferrin receptors were purified from embryonic chicken neural 
tissue by the two-column procedure summarized in Fig. I, protocol 
2. (Lane 1) Wash 4, column 2 (chicken transferrin  affinity column), 
~1  #g of protein. (Lane 2) Wash 4, column 1 (mouse monoclonal 
anti-chicken transferrin  IgG column), ~10 #g of protein. (Arrow- 
heads) Transferrin receptors (M, 56,000). 
co-migrate with the 56,000-Mr protein in peak A. 
The respective proteins in peaks A and B were tested for 
cross-reactivity against antitransferrin IgG by double immu- 
nodiffusion in agar (Fig. 7). The 56,000-Mr protein in peak A 
(receptor) failed to cross-react with mouse monoclonal anti- 
chicken transferrin  IgG  (not  shown),  or  goat  heteroclonal 
anti-chicken transferrin lgG (Fig. 7, wells 1, 3, and 5). How- 
ever, as expected, the transferrin in peak B formed a line of 
precipitation with either antibody (e.g., Fig. 7, wells 2, 4, and 
6). 
FIGURE 6  Step-elution profile of neuronal proteins from  mouse 
monoclonal antitransferrin  IgG conjugated to Sepharose 4B. Brain 
and spinal  cord  tissues (25  g)  were harvested  from  13-15-d-old 
chicken embryos and  homogenized in  10  mM  potassium  phos- 
phate,  pH  7.5 containing 150 mM  NaCl  and  0.1% Triton X-100. 
The "floating pellet" was obtained as described in Fig. 1, and was 
applied to a column of monoclonal antitransferrin  IgG conjugated 
to  Sepharose 4B.  The step  elution was developed by  using the 
buffers described in Fig. 1, protocol 1 at a flow rate of 20 ml/h. The 
column fractions  were screened  for protein by using the fluores- 
camine assay. ]he pooled, stippled peak A was found to contain a 
highly purified protein that migrated at an M, of 56,000 on SDS gel 
electrophoresis (inset  lane A).  Peak B contained several proteins 
including one  that  co-migrated  with  a  transferrin  standard  and 
another that migrated slightly more slowly than the 56,000-mol-wt 
protein (inset lane B). 
Binding of the 56,000-Mr  Protein Receptor to 
l~51-Transferrin and Its Distribution on Neurons 
Although the 56,000-MT protein could be readily purified 
using the elution scheme shown  in  protocol  1,  Fig.  1,  the 
resulting protein was devoid of  biological activity as evidenced 
by its failure to bind to immobilized transferrin or to  ~ZSl- 
transferrin. This was probably a result of denaturation due to 
the high pH (10.0) required to dissociate the 56,000-Mr  pro- 
tein from transferrin bound to very high affinity monoclonal 
IgG. As a  result, the active protein was purified from brain 
homogenates using protocol 2, Fig.  1. As this procedure used 
urea as a dissociating agent, the 56,000-Mr protein recovered 
from the  first affinity column  (mouse  antitransferrin  IgG) 
could be further purified by affinity chromatography on im- 
mobilized transferrin (Fig. 8). The affinity-purified 56,000-Mr 
protein bound radioiodinated transferrin as demonstrated by 
the gel filtration experiment shown in Fig. 9. Here, the recep- 
torJ25I-transferrin complex was eluted from the column at a 
molecular weight estimated to be 130,000 (see reference 14). 
SDS gel electrophoresis demonstrated that the 56,000-Mr 
transferrin receptor present in DRG cultures could be precip- 
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FIGURE  9  Elution  profile  of  12Sl-transferrinltransferrin-receptor 
complexes from superfine Sephadex G-200. Wash 4 of column 2, 
containing ~50 ng of transferrin-receptor protein (see Fig. 1,  pro- 
tocol  2),  was added to  81  ng of  ~2SI-Tf (4.6  #Ci/#g)  and  stored 
overnight at 4°C. The protein mixture was then separated by gel 
filtration on a calibrated, 1 x  50-cm column of superfine Sephadex 
G-200 at a flow rate of 2.0 ml/h that used equilibration buffer (Fig. 
1) as the eluent. Fractions of 0.35  ml were collected and counted 
in a "v counter (e----~). The unlabeled proteins used to calibrate 
the column were measured by the fluorescamine  assay  as described 
in  Materials and Methods (x  x). Peak C, which represents  the 
~2SI-Tf/TfR complex, was eluted from the column at a Kay of 0.125 
(130,000  mol wt). Approximately 8 ng of ~251-Tf was bound to the 
receptor in peak C. A-blue dextran (2,000,000  mol wt); B-goat IgG 
(150,000 mol wt); C-Tf/TfR complex (130,000 mol wt); D-Tf (80,000 
tool wt). 
itated  from culture  homogenates using  rabbit anti-chicken 
erythrocyte transferrin receptor IgG (Fig.  10). As a result of 
the apparent homology between the neuronal and erythrocytic 
forms of the transferrin receptor in the chicken, rabbit anti- 
chicken erythrocyte transferrin receptor IgG (14) was used to 
localize the transferrin receptors on chicken neurons in cul- 
ture. This antibody had been previously shown to react with 
the  receptor protein present on the  surface of reticulocytes 
since  it  agglutinated  embryonic chicken  red  blood cells,  a 
process which could be inhibited by preincubation with the 
Fab, fragments of this  IgG, to  cause complement-mediated 
hemolysis and to inhibit uptake of 55Fe-Tf by these cells. As 
shown in Fig.  1  1, PAP immunocytochemical localization of 
transferrin receptors revealed a  diffuse reaction product on 
the plasma membranes of cultured neurons. Control cultures 
incubated with  preimmune rabbit IgG showed no  reaction 
and are therefore not shown.  Contaminating,  non-neuronal 
cells  were also stained  by rabbit antireceptor IgG, but  the 
intensity of this staining was much less than that of neurons. 
To  demonstrate  further  the  surface  localization  of the 
56,000-M, transferrin  receptor, we carried  out  binding and 
internalization  studies  on  living  DRG  neurons  in  culture 
using Tf conjugated to FITC. After preincubation with  1% 
preimmune serum, FITC-Tf was bound to the surface mem- 
branes of DRG neurons at 4"C to yield a fine granular rim of 
surface fluorescence (23; Fig.  12A). When these cultures were 
tranferred to  a  37"C  incubator,  the  fluoresceinated Tf was 
internalized and appeared as distinct intracellular granules in 
a vesicular pattern (23; Fig.  12 B). By contrast, if cultures were 
preincubated with antitransferrin receptor IgG for 2 h at 4"C, 
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FIGURE 10  Co-migration of labeled transferrin receptors precipi- 
tated by mouse monoclonal anti-chicken transferrin IgG or by rabbit 
anti-chicken transferrin receptor lgG. DRG neurons were cultured 
as described previously (6) and labeled with [14C]leucine for 1 h as 
described in  Materials and  Methods. The  labeled neurons were 
washed and homogenized in APB buffer, and the supernatant was 
collected after centrifugation at  1,000  g  for  20  min. Aliquots of 
supernatant were mixed with either mouse monoclonal (2E 12/47) 
anti-chicken transferrin IgG (final concentration, 1:20,000) or rabbit 
anti-chicken erythrocyte transferrin receptor IgG (23; final concen- 
tration, 100 gg). After incubation overnight at 4°C, the precipitates 
were collected by centrifugation. The pellets were denatured in a 
lysis  buffer  and  electrophoresed as  described  in  Materials and 
Methods. The dried gel was fluorographed using Kodax X-Omatic 
film for 30 d at -70°C.  Notice the presence of the receptor band 
that migrates at 56,000  mol wt in  both immunoprecipitates (lanes 
A and B, top arrow). The faster-migrating band at 51,000  mol wt 
(lower arrow) was unidentified, but occasionally appeared in other 
immunoprecipitates. Lane A, precipitate obtained with mouse an+ 
titransferrin IgG; Lane B, precipitate obtained with rabbit antirecep- 
tor IgG. The migration of known standards  is indicated in relation 
to lane B. Mr, x  10  -3. 
FIGURE 11  Immunocytochemical localization of transferrin recep- 
tors on a chick embryonic DRG  neuron. DRG  neurons were cul- 
tured as described previously (6). Transferrin  receptors were local- 
ized on aldehyde-fixed cultures by the PAP technique as described 
in Materials and Methods. The primary antibody was rabbit anti- 
chicken erythrocyte transferrin receptor IgG at a concentration of 
100/~g/ml PBS (23). Notice the intense staining  on the cell body 
(arrowhead) and processes  of a  DRG  neuron. The non-neuronal 
cells  present (') reacted very weakly as compared to the staining 
observed on  DRG  or spinal  cord  neurons (not shown). Cultures 
incubated with preimmune igG showed no reaction product and 
are not shown here as a result.  Bar, 20 gin; magnification, 400. 
surface Tf receptors were blocked as no binding or internali- 
zation  of FITC-Tf was  evident  (Fig.  12C).  These  results 
appeared to confirm the surface localization of the 56,000-Mr 
transferrin receptor illustrated in Fig.  11. FiGURe 12  Antitransferrin receptor lgG blocks surface  binding of 
FITC-Tf to embryonic DRG  neurons. DRG  neurons were cultured 
on  collagen-coated glass coverslips as described in  Material and 
Methods. The cultures were preincubated in either 1% preimmune 
serum or in 45-90 ~tg of rabbit antitransferrin receptor IgG in PBS 
for 2 h at 40C.  For binding studies,  DRG cultures were incubated 
in the presence of 29-86/~g of FITC-Tf at 4"C for 2 h. For internal- 
ization studies, receptors were saturated with FITC-Tf for 30 rain at 
4"C  and then  transferred to a  37"C  incubator for 90 min. After 
binding or internalization studies, cultures were washed with PBS/ 
1%  BSA and mounted in  10 mM  para-phenylenediamine in  90% 
glycerol,  pH  8.6.  (A)  Fluorescence  photomicrograph of  FITC-Tf 
bound to a cluster of DRG  neurons at 4°C after preincubation in 
preimmune serum. Note the granular rim of surface  fluorescence 
indicated by the arrowheads. (B) FITC-Tf  internalized by a  DRG 
neuron at 37°C after preincubation in preimmune serum. Note the 
vesicular pattern of internalized FI'IC-Tf.  (C) Absence of FITC-Tf 
binding to a DRG  neuron at 4°C after preincubation in 45 pg of 
rabbit antitransferrin receptor IgG. Control experiments were car- 
ried out in the presence of 500 lzg of unconjugated Tf in order to 
assess the nonspecific binding of FITC-Tf.  Bar, 20 tLm; all micro- 
graphs shown were taken at the same magnification (400). 
DISCUSSION 
Because of the numerous trophic effects of transferrin upon 
skeletal muscle and the selective localization of this protein 
in neuronal cell bodies and processes, we had anticipated that 
this protein might represent a  myotrophic agent synthesized 
and secreted by neurons that directly regulated the metabolic 
processes of skeletal muscle (e.g., references 2 and 4). In fact, 
Stamatos et al. (9) recently  reported the synthesis oftransferrin 
by embryonic chicken spinal cord neurons in culture (see also 
reference 10). However, our present study has  shown that 
transferrin is not synthesized by cultures of spinal cord neu- 
rons (Fig. 5 B). Instead, these cultures synthesize a protein of 
Mr 56,000, which co-precipitates with transferrin in the pres- 
ence of specific antitransferrin antibodies and which appears 
to represent the neuronal receptor for transferrin. Evidence 
supporting the contention that this 56,000-Mr protein repre- 
sents the transferrin receptor includes the facts that: (a) this 
56,000-Mr protein was purified from neuronal tissue by dif- 
ferential desorption from either immobilized antitransferrin 
IgG (Fig. 6) or immobilized transferrin (Fig. 8); (b) this protein 
did not represent a  degradation product of transferrin (Fig. 
5 B); (c) this 56,000-Mr protein itself did not react with mouse 
monoclonal or goat heteroclonal IgG (Fig.  7), but did react 
with rabbit anti-chicken transferrin receptor IgG (Fig.  10; see 
reference 14); (d) this protein bound J25I-transferrin (Fig. 9); 
and  (e)  this  protein  could  be  localized on  the  surface  of 
cultured neurons by immunocytochemistry using rabbit anti- 
chicken erythrocyte transferrin-receptor IgG (Fig.  I l; see ref- 
erence  14), or  by  studies  of the  IgG  blocking  of surface 
receptors (Fig.  12). In light of this evidence, it seems reason- 
able to assume that this 56,000-Mr  protein does indeed rep- 
resent a neuronal receptor or binding protein for transferrin. 
The  transferrin  receptor from  human  HeLa cells  has  a 
turnover time of ~ 10-12 h (30). This value is in close agree- 
ment with the turnover time (8-10 h) that we observed in the 
chicken by using immunoprecipitation (Fig. 4). However, this 
t,/2 is probably only a  close estimate of the actual turnover 
time because the antibodies used in  immunoprecipitations 
were directed towards transferrin and not the receptor per se. 
Also, we were initially unable to observe the receptor protein 
in immunoprecipitates separated by SDS gel electrophoresis 
and  stained  with  Coomassie  Blue (Fig.  5A),  although  the 
radioactive protein was clearly demonstrated by fluorography 
(Fig. 5 B). It seems likely that the 56,000-Mr protein could not 
be resolved on Coomassie Blue-stained gels because the heavy 
chain oflgG migrated as a large smear of protein with an Mr 
of -55,000.  Thus, the receptor protein was  apparently ob- 
scured by the extensive heavy chain band of IgG. However, 
the receptor protein can be readily visualized by Coomassie 
Blue in the absence of IgG and migrates at an M~ of 56,000 
(e.g., inset,  Fig. 6). 
Several plasma  proteins  including transferrin  have been 
localized within neuronal tissues (31-33). Schachter and To- 
ran-Allerand (34) have shown that these intraneuronal pro- 
teins are not  synthesized by neuronal tissue (however, see 
reference 10). Instead,  these proteins appear to reach their 
target neurons by uptake  followed by retrograde transport 
(see also references 31  and 33).  Transferrin is known to be 
transported into cells by binding to  high-affinity receptors 
localized on the cell surface (35-39) followed by receptor- 
mediated endocytosis (e.g., reference 35). Therefore, our ob- 
servations that  the transferrin receptor is  synthesized both 
rapidly  and  in  abundance  (7%  of incorporated  label)  by 
cultured neurons and co-precipitates with antitransferrin an- 
tibodies (implying that this receptor is present as a receptor- 
ligand complex) may help to explain the intraneuronal local- 
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apparent abundance oftransferrin in peripheral nervous tissue 
(40). 
A surprising aspect of this study concerns the quantitative 
difference in the cytological levels of immunoreactive trans- 
ferrin (Fig. 5 C) or transferrin receptors (Fig.  1  I) in neurons 
as contrasted to the relatively low levels observed in contam- 
inating non-neuronal cells. The immunocytochemical visu- 
alization of transferrin was performed on intact ceils fixed in 
absolute  methanol  using  high-affinity  rabbit  anti-chicken 
transferrin antibodies (Fig. 5 C). Because of the de-lipidating 
properties  of methanol,  the  immunocytochemical pattern 
observed probably reflects any transferrin that had been in- 
ternalized by these cells as well as transferrin that had been 
associated with the plasma membrane. The results shown in 
Fig. 5 agree with our previous study on the immunocytochem- 
ical localization of transferrin in adult or embryonic chicken 
neurons, which also demonstrated increased immunoreactiv- 
ity within sectioned or intact neuronal tissues as compared 
with  low  levels  of reactivity in  muscle,  liver,  or,  stromal 
elements (6). These results also appear to reflect our obser- 
vation that transferrin comprises ~2.6%  of soluble axonal 
protein (40).  By contrast, the immunocytochemical visuali- 
zation of transferrin receptors was performed on intact cells 
fixed in cold 4%  paraformaldehyde-0.1% glutaraldehyde in 
100 mM sodium cacodylate, pH 7.2, using rabbit anti-chicken 
erythrocyte transferrin receptor IgG (Fig.  11; reference 14). 
These  antibodies  were  shown  to  agglutinate  embryonic 
chicken erythrocytes, a  process that could be inhibited by 
preincubation with the F~b, fragments of this IgG, to cause 
complement-mediated red cell lysis and to inhibit the uptake 
of SSFe-Tf by these cells (14).  Because the neuron shown in 
Fig.  11  was an intact cell fixed with cold aldehyde fixative, 
and as no attempt was made to solubilize the cell membrane 
during the PAP procedure, the immunocytochemical pattern 
observed probably reflects surface receptors. This  is  more 
convincingly demonstrated by the inhibition of surface fluo- 
rescence shown on the neuron in Fig.  12C which was pre- 
treated with antitransferrin receptor lgG and then incubated 
in the presence of FITC-Tf at 4"C. Therefore, the difference 
in  the  staining  intensity  visible  in  Fig.  11  may  reflect a 
quantitative difference in the number of surface transferrin 
receptors on neurons although this supposition will have to 
be investigated further at either the  electron microscopical 
level or by isotopic binding experiments. 
The transferrin receptor from human tissues or human cell 
lines is  a  glycoprotein that  migrates at  an  M,  of 90,000- 
100,000 on SDS gels (20,  37, 41, 42). No ready explanation 
can be given to account for the smaller size (Mr 56,000) of 
the chicken neuronal transferrin receptor especially in that 
this protein was purified by a procedure similar to that used 
to isolate this receptor from human placenta (20). On certain 
occasions, immunoprecipitates separated by gel electropho- 
resis revealed a second labeled protein band which migrated 
more quickly than the  56,000-Mr  protein (Mr  51,000;  Fig. 
10). Although compelling evidence suggests that the 56,000- 
Mr protein contains the binding moiety for transferrin (Figs. 
5, 6, 8, 9; see also reference 14), it may be that this smaller 
polypeptide represents a degradation product of the 56,000- 
Mr protein because no serine or sulphydryl protease inhibitors 
were present in the tissue homogenization buffer (14), or this 
51,000-Mr  protein might be a structural filamentous protein 
involved in membrane anchorage of the receptor. Clearly, the 
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identity of this 51,000-Mr band must await further investiga- 
tion. In any case, the fact that the transferrin-binding moiety 
of the transferrin receptor in neurons (56,000 mol wt) is of 
an almost identical molecular weight to that in chicken retic- 
ulocytes (59,000  mol  wt,  reference  14), and  the  fact that 
antibodies against this erythrocytic receptor cross-react with 
the  56,000  mol  wt  protein  on  the  surface  membrane  of 
neurons suggest that the transferrin receptor in chicken tissues 
may have a uniquely different composition from that of the 
human and other mammals. It seems clear that the physico- 
chemical parameters of this chicken receptor protein, includ- 
ing a clarification of the identity of the 51,000 mol wt band, 
will  have to be studied  in  more detail  before any further 
comparisons can be made to the mammalian receptor. 
The protocol for purifying transferrin receptors described 
by Seligman et at. (20) depends upon two major features:  (a) 
the  use  of detergent  in  the  extraction buffer in  order  to 
solubilize the  membrane-bound  receptor; and  (b)  mainte- 
nance of a tight binding interaction between transferrin and 
its receptor on the immunoabsorption column until the spe- 
cific alkaline desorption step. These authors used Triton X- 
100 to solubilize the ligand-receptor complex from placental 
tissue  although  recent data  suggest  that  0.4%  SDS  is  far 
superior for this purpose (29). We too found that complete 
extraction of  the 56,000 tool wt protein from neuronal tissues 
required the presence of detergent because most detergent- 
free buffers were almost totally ineffective for this purpose. 
However, we have obtained preliminary data that demon- 
strates that 10 mM citrate buffer, pH 4.2, extracts a significant 
proportion of the receptor protein from neuronal tissue (for 
rationale, see reference 28). If the resulting membrane pellet 
is  reextracted with  equilibration  buffer,  a  further pool  of 
receptors is obtained. These data appear to support the view 
that neuronal transferrin receptors may exist in two separate 
pools: an intracellular pool extractable by citrate, and a mem- 
brane-bound pool extractable only with detergent. For de- 
sorbing transferrin  receptors  from  the  immunoabsorption 
column (Fig. 1, protocol 1), we chose borate buffer at pH 10.0 
over glycine/NaOH because glycine interfered with the flu- 
orescent assay used in constructing elution profiles. However, 
as either borate or glycine/NaOH appeared to denature the 
receptor, we ultimately used a urea/Triton buffer for desorp- 
tions (Fig.  1, protocol 2). We are now experimenting with a 
variety of other desorbents in the hope of obtaining active 
receptors in higher yields. 
Transferrin appears to have very pronounced growth-regu- 
lating properties because blocking the transfen'in receptor of 
human tumor cell lines with antireceptor monoclonal anti- 
bodies dramatically  reduces  cell growth  (43).  In  fact,  the 
presence of the transferrin receptor on the surface of normal 
or neoplastic cells undergoing division appears to correlate 
with cellular proliferation (39).  In light  of these findings,  it 
remains to be seen what role transferrin plays in neuronal 
differentiation and metabolism (32) and why this protein is 
required in such abundance by neuronal tissues (6, 40). This 
appears to be a highly relevant question since it was recently 
reported that transferrin is an essential component for the 
differentiation and maintenance of  sensory neurons in culture 
(44).  In  this regard,  unpublished studies in  our laboratory 
have demonstrated that cultured chicken DRG neurons in- 
ternalize ~/5I-transferfin by a specific,  receptor-mediated en- 
docytotic mechanism  (Markelonis, G.  J.,  T.  H.  Oh,  L.  P. 
Park, P. Azari, and S. R. Max, unpublished). In view of the fact that transferrin selectively appears in the cerebrospinal 
fluid of patients with  amyotrophic lateral  sclerosis  (45),  a 
degenerative disease of motor neurons, it may be that this 
protein plays some important yet unrecognized role in neu- 
ronal survival. 
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